newsfilter
← Latest News
GlobeNewswire·

Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors

MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN) a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions,